Novo Nordisk shares jumped 10% on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill, giving the Danish drugmaker a competitive edge over rival Eli Lilly in the ...
Hyperion DeFi, Inc. OverviewBiotechnology / Healthcare Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback